Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
10298 | 1009 | 39.3 | 87% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1728 | 6064 | ACUTE PROMYELOCYTIC LEUKEMIA//ARSENIC TRIOXIDE//SUMO |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ARSENIC TRIOXIDE | Author keyword | 325 | 51% | 45% | 459 |
2 | AS2O3 | Author keyword | 14 | 36% | 3% | 32 |
3 | ARSENIC TRIOXIDE AS2O3 | Author keyword | 12 | 56% | 1% | 15 |
4 | ORGANIC ARSENICALS | Author keyword | 6 | 80% | 0% | 4 |
5 | TETRAARSENIC OXIDE | Author keyword | 6 | 80% | 0% | 4 |
6 | ARSENIC DISULFIDE | Author keyword | 6 | 100% | 0% | 4 |
7 | DARINAPARSIN | Author keyword | 4 | 67% | 0% | 4 |
8 | ARSENIC METABOLITE | Author keyword | 4 | 75% | 0% | 3 |
9 | ARSTHINOL | Author keyword | 4 | 75% | 0% | 3 |
10 | MICRORNA 491 | Author keyword | 4 | 75% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ARSENIC TRIOXIDE | 325 | 51% | 45% | 459 | Search ARSENIC+TRIOXIDE | Search ARSENIC+TRIOXIDE |
2 | AS2O3 | 14 | 36% | 3% | 32 | Search AS2O3 | Search AS2O3 |
3 | ARSENIC TRIOXIDE AS2O3 | 12 | 56% | 1% | 15 | Search ARSENIC+TRIOXIDE+AS2O3 | Search ARSENIC+TRIOXIDE+AS2O3 |
4 | ORGANIC ARSENICALS | 6 | 80% | 0% | 4 | Search ORGANIC+ARSENICALS | Search ORGANIC+ARSENICALS |
5 | TETRAARSENIC OXIDE | 6 | 80% | 0% | 4 | Search TETRAARSENIC+OXIDE | Search TETRAARSENIC+OXIDE |
6 | ARSENIC DISULFIDE | 6 | 100% | 0% | 4 | Search ARSENIC+DISULFIDE | Search ARSENIC+DISULFIDE |
7 | DARINAPARSIN | 4 | 67% | 0% | 4 | Search DARINAPARSIN | Search DARINAPARSIN |
8 | ARSENIC METABOLITE | 4 | 75% | 0% | 3 | Search ARSENIC+METABOLITE | Search ARSENIC+METABOLITE |
9 | ARSTHINOL | 4 | 75% | 0% | 3 | Search ARSTHINOL | Search ARSTHINOL |
10 | MICRORNA 491 | 4 | 75% | 0% | 3 | Search MICRORNA+491 | Search MICRORNA+491 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AS2O3 | 95 | 60% | 10% | 103 |
2 | TRIOXIDE AS2O3 | 18 | 40% | 3% | 35 |
3 | TRIOXIDE INDUCES APOPTOSIS | 14 | 53% | 2% | 19 |
4 | TRIOXIDE INDUCED APOPTOSIS | 9 | 31% | 2% | 25 |
5 | INCREASED MITOTIC ARREST | 8 | 100% | 0% | 5 |
6 | ARSENIC TRIOXIDE AS2O3 | 7 | 21% | 3% | 29 |
7 | ACID COMBINATION THERAPY | 7 | 57% | 1% | 8 |
8 | CGL 2 CELLS | 6 | 80% | 0% | 4 |
9 | SPECIES DEPENDENT PATHWAY | 6 | 80% | 0% | 4 |
10 | ARSENIC INDUCES APOPTOSIS | 6 | 100% | 0% | 4 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Arsenical-based cancer drugs | 2007 | 145 | 178 | 63% |
Arsenic trioxide - An old drug rediscovered | 2010 | 80 | 72 | 57% |
Mechanisms of action of arsenic trioxide | 2002 | 533 | 100 | 35% |
Biological Responses to Arsenic Compounds | 2009 | 61 | 58 | 53% |
Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma | 2008 | 50 | 22 | 64% |
Environmental toxicity, oxidative stress and apoptosis: Menage a Trois | 2009 | 156 | 408 | 20% |
The potential of arsenic trioxide in the treatment of malignant disease: past, present, and future | 2004 | 103 | 114 | 48% |
From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia | 2011 | 46 | 159 | 26% |
Arsenic compounds in the treatment of multiple myeloma: A new role for a historical remedy | 2006 | 34 | 28 | 79% |
Arsenic compounds: revived ancient remedies in the fight against human malignancies | 2012 | 17 | 67 | 37% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOL CELL BIOL FUNCT GENOM | 4 | 75% | 0.3% | 3 |
2 | ENVIRONM CHEMODYNAM | 3 | 40% | 0.6% | 6 |
3 | CHINESE PLA CANC | 1 | 50% | 0.2% | 2 |
4 | LAMABIO | 1 | 50% | 0.2% | 2 |
5 | SAMUEL WAXMAN CANC FDN | 1 | 50% | 0.2% | 2 |
6 | THER EUT HEMATOL TRADIT CHINESE MED | 1 | 100% | 0.2% | 2 |
7 | NIH RCMI ENVIRONM HLTH | 1 | 33% | 0.3% | 3 |
8 | ENVIRONM GENOM INTEGRAT BIOL | 1 | 16% | 0.5% | 5 |
9 | TUMOUR METAB GRP | 1 | 33% | 0.2% | 2 |
10 | ADV MICROSCOPY CMA BIO BIO | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000192556 | ACUTE PROMYELOCYTIC LEUKEMIA//PML RAR ALPHA//APL |
2 | 0.0000187096 | REALGAR//ALACRANITE//PARAREALGAR |
3 | 0.0000166062 | ARSENIC//ARSENITE//DIMETHYLARSINIC ACID |
4 | 0.0000068824 | PDXP//SITEP PHASE UNIT 1//DIOC23 |
5 | 0.0000068347 | GALLIC ACID//TOONA SINENSIS//AS41 |
6 | 0.0000061787 | DAXX//PML//PML NUCLEAR BODIES |
7 | 0.0000044846 | JWA//MOL CELL BIOL TOXICOL//GLYCEROPHOSPHOINOSITOL |
8 | 0.0000042947 | IMEXON//1 4 DIHYDRO 2 3 QUINOXALINEDIONE//CYANOAZIRIDINE |
9 | 0.0000040350 | ARSONOLIPOSOMES//ARSONOLIPIDS//ARSONIC ACIDS |
10 | 0.0000038785 | DENT PHARM 3126//CYP3A23//CYPLAL |